STLN

Starling Oncology, Inc.

Latest Form 4:Sale$1.9MbyHively Brad (Director) · filed Aug 24, 2026

Starling Oncology, Inc. (STLN) has 2 SEC Form 4 filings (2 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Aug 24, 2026.

Insiders have net sold $1.9M over the trailing 6 months.

  • Industry:Medical - Care Facilities
  • Employees:641
  • HQ:Cerritos, CA, US
  • IPO:2026-08-04

Insider Buying

$78K

reported purchases (SEC code P)

Insider Selling

$1.9M

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Market Cap

$628.8M

latest known value

Source
Hively BradFirst in 8 months
Sale$1.9MAug 24SEC ↗
Purchase$78KAug 17SEC ↗

Related companies

Starling Oncology, Inc. is in the Healthcare sector.